SCHEMBL25925010

SCHEMBL25925010

CC(=O)c1cn(CC(=O)O)c2ccc(C)cc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.53
LMNA P02545 4/20 0.53
HTT P42858 3/20 0.53
RAB9A P51151 3/20 0.53
POLB P06746 2/20 0.53
RXFP1 Q9HBX9 2/20 0.51
P2RY12 Q9H244 2/20 0.51
PTGDR2 Q9Y5Y4 2/20 0.49
KMT2A Q03164 3/20 0.49
CREBBP Q92793 1/20 0.49
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 2/20 0.48
NPC1 O15118 1/20 0.47
MAPT P10636 2/20 0.46
CYP3A4 P08684 2/20 0.45
CYP2D6 P10635 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
MEN1 O00255 1/20 0.45
CYP1A2 P05177 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25925383 0.88 SMN1; SMN2 (0.53) SMN1; SMN2LMNAHTTRAB9APOLB
SCHEMBL17023484 0.85 KMT2A (0.49) SMN1; SMN2LMNAHTTRAB9ARXFP1
SCHEMBL13539148 0.85 LMNA (0.49) SMN1; SMN2LMNAHTTRAB9APOLB
SCHEMBL17023688 0.84 CFD (0.49) SMN1; SMN2LMNAKMT2ACREBBPALDH1A1
SCHEMBL29781757 0.84 CFD (0.49) SMN1; SMN2LMNAKMT2ACREBBPALDH1A1
SCHEMBL18572850 0.83 LMNA (0.55) SMN1; SMN2LMNAHTTRAB9APOLB
SCHEMBL18554040 0.82 PTGDR2 (0.47) SMN1; SMN2LMNAHTTRAB9APOLB
SCHEMBL12480373 0.82 ALDH1A1 (0.56) SMN1; SMN2LMNARAB9AKMT2ACREBBP
SCHEMBL17053136 0.81 SMN1; SMN2 (0.47) SMN1; SMN2LMNAHTTRAB9APOLB
SCHEMBL12481690 0.81 PTGDR2 (0.51) SMN1; SMN2LMNARAB9APTGDR2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230218578-A1 BENZOPYRAZOLE COMPOUNDS AND ANALOGUES THEREOF WILMINGTON TRUST, NATIONAL ASSOCIATION 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230218578-A1 BENZOPYRAZOLE COMPOUNDS AND ANALOGUES THEREOF C9, C5, C1QBP SMN1; SMN2 2279/4885LMNA 1451/4885HTT 2806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.